search
Back to results

Image-guided Navigation During Robotic Sentinel Node Removal (N21LND)

Primary Purpose

Prostate Cancer

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Image-guided navigation
Sponsored by
The Netherlands Cancer Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Prostate Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria: Scheduled for abdominal robotic sentinel node resection ≥ 18 years old Provided written 'informed consent' Sentinel nodes should be fixed relative to retroperitoneal structures or major vessels. Exclusion Criteria: Metal hip implants / implants in the pelvic area Pacemaker, defibrillator

Sites / Locations

  • Netherlands Cancer InstituteRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients scheduled for sentinel node procedure

Arm Description

This is a single-center observational feasibility study to evaluate the overall performance of the surgical navigation system during robotic surgery, without impact on the surgical procedure itself. The duration of this study will be approximately 2.5 years. Patients scheduled for a sentinel node procedure at the NKI are eligible for inclusion. Patients are informed about the study before the planned surgery and, after being provided with the necessary information regarding participation in the study, will be asked for informed consent. No additional risk is expected using the NDI navigation setup. Patients will receive some additional radiation due to the CT scan during surgery; a perioperative CBCT scan (~ 4 mSv) is acquired. This extra dose is low, considering other standard imaging in these patients like, pre-operative imaging with SPECT/CT scans. After surgery, no further participation or cooperation of the patient is required.

Outcomes

Primary Outcome Measures

Feasibility of image-guide assisted sentinel node removal
The percentage of successful image-guide assisted sentinel nodes removed, in which failure is defined as sentinel nodes which are per-operatively incorrectly identified as target SN by the navigation.

Secondary Outcome Measures

Usability of image-guided navigation
Evaluation of the usability of the image-guided navigation will be evaluated using the system usability scale (SUS). This scale ranges from 0-100 where a higher score means a better outcome.
Time
Time to localization and removal of the sentinel node and total surgical time will be recorded.

Full Information

First Posted
October 13, 2023
Last Updated
October 13, 2023
Sponsor
The Netherlands Cancer Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT06091072
Brief Title
Image-guided Navigation During Robotic Sentinel Node Removal
Acronym
N21LND
Official Title
Feasibility of in Vivo Image-guided Navigation During Robotic Sentinel Node Removal
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
August 1, 2024 (Anticipated)
Study Completion Date
August 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Netherlands Cancer Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Image-guided navigation based on pre-operative imaging can give the surgeon more insight into the location of the sentinel nodes in relation to other anatomical structures. The purpose of the study is to investigate the feasibility of image-guided navigation during robot-assisted surgery to treat cancer in the pelvic area.Ultimately, the application of navigation during robot-assisted sentinel node dissection could potentially improve the outcome of surgery for the patient.
Detailed Description
Image-guided navigation surgery allows for full utilization of pre-operative imaging during surgery, and has the potential of reducing both irradical resections and morbidity. It has successfully been applied in the AvL for open abdominal surgery, however more and more surgeries are being performed less invasive using robot surgery. Rapid extension of robot-assisted surgery has increased the need for robot-compliant image-guided techniques. Unfortunately, tactile feedback is lacking in these robotic surgeries, which increases the additional value of image-guided navigation. In this study, patients will undergo an abdominal sentinel node dissection in order to evaluate the actual technical benefit of robotic navigation. This is the first feasibility study towards clinical implementation of the navigation setup into robot-assisted image-guided navigation surgery. The results of this study will be the base for new studies, evaluating the clinical benefit of image-guided navigation for robot surgeries.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
One group to evaluate the feasibility of the proposed method.
Masking
None (Open Label)
Allocation
N/A
Enrollment
55 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients scheduled for sentinel node procedure
Arm Type
Experimental
Arm Description
This is a single-center observational feasibility study to evaluate the overall performance of the surgical navigation system during robotic surgery, without impact on the surgical procedure itself. The duration of this study will be approximately 2.5 years. Patients scheduled for a sentinel node procedure at the NKI are eligible for inclusion. Patients are informed about the study before the planned surgery and, after being provided with the necessary information regarding participation in the study, will be asked for informed consent. No additional risk is expected using the NDI navigation setup. Patients will receive some additional radiation due to the CT scan during surgery; a perioperative CBCT scan (~ 4 mSv) is acquired. This extra dose is low, considering other standard imaging in these patients like, pre-operative imaging with SPECT/CT scans. After surgery, no further participation or cooperation of the patient is required.
Intervention Type
Other
Intervention Name(s)
Image-guided navigation
Intervention Description
A patient-specific 3D model will be created using an available pre-operative SPECT/CT scan. Pre-operatively, three electromagnetic patient trackers will be attached to the patients' skin, close to the pelvis, allowing tracking the patient's position during surgery. After anesthesia and before the skin disinfection procedure, the patient is placed in the final surgical position, where an intra-operative CBCT scan is performed required for the image-guided surgery workflow. During surgery, the preoperative images and 3D model will be visible for the surgeon together with a blunt-tip electromagnetic pointer enabling surgical navigation during robotic surgery. Anatomical structures will be used to validate the accuracy of the navigation. When the target is identified by the surgeon, the pointer is used to store the location digitally. Scheduled standard clinical 99mTc will be used as validation for target(s) identification.
Primary Outcome Measure Information:
Title
Feasibility of image-guide assisted sentinel node removal
Description
The percentage of successful image-guide assisted sentinel nodes removed, in which failure is defined as sentinel nodes which are per-operatively incorrectly identified as target SN by the navigation.
Time Frame
One day
Secondary Outcome Measure Information:
Title
Usability of image-guided navigation
Description
Evaluation of the usability of the image-guided navigation will be evaluated using the system usability scale (SUS). This scale ranges from 0-100 where a higher score means a better outcome.
Time Frame
One day
Title
Time
Description
Time to localization and removal of the sentinel node and total surgical time will be recorded.
Time Frame
One day

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Scheduled for abdominal robotic sentinel node resection ≥ 18 years old Provided written 'informed consent' Sentinel nodes should be fixed relative to retroperitoneal structures or major vessels. Exclusion Criteria: Metal hip implants / implants in the pelvic area Pacemaker, defibrillator
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laura Aguilera Saiz, MSc
Phone
+31205127491
Email
l.aguilera@nki.nl
Facility Information:
Facility Name
Netherlands Cancer Institute
City
Amsterdam
State/Province
North Holland
ZIP/Postal Code
1066CX
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Aguilera Saiz, MSc
Phone
+31205127491
Email
l.aguilera@nki.nl
First Name & Middle Initial & Last Name & Degree
Laura Aguilera Saiz, MSc
First Name & Middle Initial & Last Name & Degree
Theo Ruers, Prof. Dr.
First Name & Middle Initial & Last Name & Degree
Wout Heerink, Dr.
First Name & Middle Initial & Last Name & Degree
Harald Groen, Dr.

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Image-guided Navigation During Robotic Sentinel Node Removal

We'll reach out to this number within 24 hrs